Central-Line Associated Blood Stream Infections (CLABSI) PreventionHelps teams prevent, recognize, treat, and report CLABSI
|Type:||Analytic Accelerator||Status:||Analytic Services||Revised:||2019-Jul-23|
The Central-Line Associated Bloodstream Infection (CLABSI) Prevention Analytics Accelerator provides data and visualizations that help users review outcomes and trends related to CLABSI, efficiently assess and prioritize CLABSI risk, and intervene to prevent and/or treat CLABSI. The application also provides near real-time analysis of internal processes related to CLABSI to support care improvement.
Note that this application, like all Health Catalyst analytic accelerators, is implemented in a custom way; organizations identify their own areas of focus, process aims, and outcome goals. For this reason, the appearance and functionality of the application may differ from what is presented here.
The CLABSI Prevention application gives insight into clinical outcomes (e.g., CLABSI rate, LOS) and adherence to best-practice care standards.
Background & Problem Summary
Organizations choose to implement this application to address these issues:
- CLABSI is common, dangerous, and preventable. Central venous catheters are the most common cause of healthcare-associated bloodstream infections—and the mortality rate for CLABSI patients ranges up to 25%. Analyses suggest that the majority of CLABSIs are preventable if evidence-based best practices are followed.
- Costs associated with CLABSI are high. In the U.S., the annual costs associated with CLABSI may be as high as $2.3 billion. Cost per CLABSI is estimated to range from $34,508 to $56,000.
- Evidence-based best practice guidelines are available, but adherence is inconsistent. Surveys of clinicians consistently find variable rates of reported compliance to guideline recommendations for central-line insertion (hand hygiene, chlorhexidine, full barrier precaution). Other studies have reported low compliance with certain individual elements of CLABSI bundles despite the fact that the greatest CLABSI rate reductions are achieved with ≥95% compliance with all bundle practices.
Helps teams prevent, recognize, treat, and report CLABSI
The CLABSI Prevention Analytic Accelerator supports a disciplined, data-driven approach to efforts to reduce CLABSI and associated mortality and morbidity, hospital length of stay, and costs. Typical implementations focus on central-line utilization and adherence to best-practice care bundles for central-line insertion and maintenance—areas where getting it right is especially meaningful.
Benefits and Features
- Access an at-a-glance, near real-time view of clinical outcomes and the care practices that drive them. The application visualizes outcome metrics (CLABSI rate, central-line utilization, excess cost, etc.) in relation to adherence to line insertion and maintenance bundles.
- Rapidly identify, analyze, and improve. The application enables you to identify the hospital care location where patients are at increased risk of developing CLABSI based on device utilization and bundle compliance. You can also drill down to the facility, unit, service, or patient level to analyze performance further, provide feedback, and support measurement of performance improvement interventions.
- Increase efficiency and accuracy of reporting. Application dashboards are interactive and give the surveillance team the ability to evaluate cases flagged as at-risk, along with supporting clinical details, to help reviewers make the final determination of CLABSI cases prior to NHSN submission.
- Hospital infection prevention teams
- Clinical directors, service-line leadership and teams
- Clinical educators
- Unit-level leadership and teams
- Quality improvement teams
- The Director of the ICU and the clinical educator want to know if recent provider education efforts have improved adherence to the insertion and maintenance bundles—and whether adherence has impacted the hospital’s CLABSI rate. They use the accelerator to learn that since a checklist was rolled out, the insertion bundle adherence has gone up and the CLABSI rate has come down. However, they also see that adherence to one component of the bundle—placing a physician order for maintenance—continues to lag behind target. They make a plan to focus on this aspect of best practice care and use the accelerator to monitor these metrics going forward.
- An Infection Preventionist uses the CLABSI accelerator every day to review data on central-line patients: how many days each has had the line, their medical service and unit, the indication for the line, and the associated compliance with care bundles (maintenance and insertion). This helps her identify patients at higher risk for CLABSI and work with the unit nurses and physicians to follow up to close care gaps and to remove lines as soon as they are no longer indicated.
This product may leverage one or more of the following sources:
|Primary:||EMR - Clinical||See data sources of this type|
|Secondary:||Finance/Costing||See data sources of this type|
Additional Data Source Information
- Laboratory data sources
- Event-reporting and surveillance tools such as Vigilanz, TheraDoc, etc.
- CLABSI rate
- Central-line utilization (insertion, duration)
- Length of stay
- Cost per case
- Process measures: documentation of central-line indication, adherence to insertion bundle, adherence to maintenance bundle
- Designing Hospital Quality Function Around the Value Chain
- Hospital Acquired Infections — How to Reduce Surveillance Waste